Evidence map›Paper›PMID 42595880›Full record

ReviewHypertension research : official journal of the Japanese Society of Hypertension2026

Developmental origins of hypertension and renal injury: epigenetic memory in renal stem and progenitor cells.

Shoichi Shimizu, Noboru Fukuda, Nobuhiko Nagano, Ichiro Morioka

Abstract readReview
PubMed Publisher
In one paragraph

Review in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shoichi ShimizuDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan. shimizu.shoichi@nihon-u.ac.jp.
Noboru FukudaUkima Central Hospital, Tokyo, Japan.
Nobuhiko NaganoDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Ichiro MoriokaDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The developmental origins of health and disease (DOHaD) theory proposes that environmental exposure during critical periods of fetal and early postnatal development induces long-lasting biological changes that shape health trajectories across the lifespan. Hypertension and renal injury are adult-onset conditions associated with developmental programming that may increase the risk of non-communicable diseases later in life. Traditionally, reduced nephron endowment and subsequent glomerular hyperfiltration have been considered the principal mechanisms linking adverse fetal environments to subsequent hypertension and kidney disease. However, this paradigm does not fully explain the delayed onset or heterogeneity of these conditions. Accumulating evidence indicates that epigenetic regulation is a key mechanism by which early-life adversity is recorded. Renal stem and progenitor cells have emerged as cellular substrates for developmental programming, retaining information acquired during organogenesis, and influencing renal and vascular homeostasis later in life. Experimental studies have suggested that fetal malnutrition induces persistent epigenetic alterations in these cells, leading to altered differentiation, impaired repair capacity, and dysregulation of the intrarenal renin-angiotensin system, thereby increasing susceptibility to hypertension and renal injury in adulthood. Additionally, metabolic programming may interact with epigenetic regulation through sustained alterations in mitochondrial function and key metabolites. This mini-review summarizes the current evidence linking developmental programming to hypertension and renal injury, focusing on epigenetic regulation in renal stem and progenitor cells and metabolic alterations observed at the renal tissue level. We also discuss the reversibility, clinical implications for early life surveillance, and future directions for life-course strategies to prevent hypertension and renal injury. Graphical abstract. Developmental programming of hypertension and renal injury: epigenetic and metabolic memory. Adverse early-life environments, including fetal malnutrition, fetal growth restriction, ischemia, and prematurity, may program epigenetic memory in renal stem and progenitor cells and metabolic alterations in renal tissue. Epigenetic-metabolic interactions contribute to persistent abnormalities in renal mesenchymal stem cell (MSC) differentiation, intrarenal renin-angiotensin system (RAS) activation, injury-induced activation of label-retaining cells (LRCs), and endothelial progenitor cell (EPC)-mediated vascular repair. Postnatal nutrition, high salt intake, obesity, kidney injury, and ageing may amplify this vulnerability, promoting adult hypertension and renal injury and increasing long-term susceptibility to CKD. Maternal nutrition and supplementation, early surveillance, and lifestyle intervention represent potentially modifiable windows across the life course.

Indexed as

Epigenesis, GeneticHypertensionKidneyKidney DiseasesStem CellsAnimalsDevelopmental Origins of Health and DiseaseEpigenetic MemoryHumansPregnancyDOHaDEpigeneticHypertensionRenal injuryStem cell memory

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.